Estech developed a range of cutting-edge cardiac surgery tools addressing three high growth areas in cardiac surgery:
A full RF ablation platform for minimally invasive procedures, a range of surgical instruments for least invasive valve (LIV) procedures and a suite of products for CABG procedures.
Stage Capital invested in Estech in 2009 and merged the company with NASDAQ listed Atricure in December 2013.
Venture-stage investment in medical technology
STAGE CAPITAL TEAM